Literature DB >> 8482974

The Extended Disability Status Scale (EDSS) as a predictor of impairments of functional activities of daily living in multiple sclerosis.

R A Cohen1, H R Kessler, M Fischer.   

Abstract

We investigated the relationship between the Kurtzke expanded disability status scale (EDSS) and an activities of daily living (ADL) scale that assesses disability across multiple functional domains based on self report of patients with multiple sclerosis (MS). Forty-three patients with definite MS responded on a 42-item ADL inventory and were also assigned an EDSS rating as part of their regular clinical examination. While a strong correlation was found between the EDSS and total ADL disability level, the ADL domain of 'Mobility' fully accounted for this relationship. The distribution of ADL scores as a function of EDSS level was curvilinear, as ADL variance was inconsistent across EDSS levels. Little ADL disability was evident when EDSS levels were below five. At higher EDSS levels, ADL variability increased substantially, making predictions regarding ADL level less exact.

Entities:  

Mesh:

Year:  1993        PMID: 8482974     DOI: 10.1016/0022-510x(93)90215-k

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

1.  Normal appearing white matter permeability: a marker of inflammation and information processing speed deficit among relapsing remitting multiple sclerosis patients.

Authors:  Eldar Eftekhari; Seyed-Parsa Hojjat; Rita Vitorino; Timothy J Carroll; Charles Grady Cantrell; Liesly Lee; Matthew W Taylor; Sarah A Morrow; Haddas Benhabib; Richard I Aviv; Andrea Kassner
Journal:  Neuroradiology       Date:  2017-06-16       Impact factor: 2.804

2.  Serial analysis of magnetization-transfer histograms and Expanded Disability Status Scale scores in patients with relapsing-remitting multiple sclerosis.

Authors:  U J Patel; R I Grossman; M D Phillips; J K Udupa; J C McGowan; Y Miki; L Wei; M Polansky; M A van Buchem; D Kolson
Journal:  AJNR Am J Neuroradiol       Date:  1999 Nov-Dec       Impact factor: 3.825

Review 3.  What We Learned from The History of Multiple Sclerosis Measurement: Expanded Disability Status Scale.

Authors:  Bilge Piri Çinar; Yüksel Güven Yorgun
Journal:  Noro Psikiyatr Ars       Date:  2018       Impact factor: 1.339

4.  FutureMS cohort profile: a Scottish multicentre inception cohort study of relapsing-remitting multiple sclerosis.

Authors:  Patrick K A Kearns; Sarah J Martin; Jessie Chang; Rozanna Meijboom; Elizabeth N York; Yingdi Chen; Christine Weaver; Amy Stenson; Katarzyna Hafezi; Stacey Thomson; Elizabeth Freyer; Lee Murphy; Adil Harroud; Peter Foley; David Hunt; Margaret McLeod; Jonathon O'Riordan; F J Carod-Artal; Niall J J MacDougall; Sergio E Baranzini; Adam D Waldman; Peter Connick; Siddharthan Chandran
Journal:  BMJ Open       Date:  2022-06-29       Impact factor: 3.006

Review 5.  Outcome Measures in Clinical Trials for Multiple Sclerosis.

Authors:  Caspar E P van Munster; Bernard M J Uitdehaag
Journal:  CNS Drugs       Date:  2017-03       Impact factor: 5.749

6.  Review of the clinical evidence for interferon beta 1a (Rebif) in the treatment of multiple sclerosis.

Authors:  Francesco Manfredonia; Livia Pasquali; Angela Dardano; Alfonso Iudice; Luigi Murri; Fabio Monzani
Journal:  Neuropsychiatr Dis Treat       Date:  2008-04       Impact factor: 2.570

Review 7.  Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis.

Authors:  Sandra Meyer-Moock; You-Shan Feng; Mathias Maeurer; Franz-Werner Dippel; Thomas Kohlmann
Journal:  BMC Neurol       Date:  2014-03-25       Impact factor: 2.474

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.